BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10178695)

  • 1. Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome.
    Borghardt EJ; Kirchertz EJ; Marten I; Fenchel K
    Transfus Sci; 1998 Mar; 19 Suppl():5-7. PubMed ID: 10178695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
    Mistry B; Kimmel PL; Hetzel PC; Phillips TM; Braden GL
    Am J Kidney Dis; 2004 Oct; 44(4):e50-8. PubMed ID: 15384034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME; Hoffmann W; Belka C; Bamberg M
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.
    Catalano C; Gianesini C; Fabbian F
    Nephron; 2002 Jun; 91(2):324-6. PubMed ID: 12053072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.
    Kasper S; Neurath MF; Huber C; Theobald M; Scharrer I
    Transfusion; 2007 Jul; 47(7):1263-7. PubMed ID: 17581162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
    Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
    Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy.
    Groff JA; Kozak M; Boehmer JP; Demko TM; Diamond JR
    Am J Kidney Dis; 1997 Feb; 29(2):280-4. PubMed ID: 9016902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin-C induced hemolytic uremic syndrome: a case report.
    Gundappa RK; Sud K; Kohli HS; Gupta KL; Joshi K; Sakhuja V
    Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
    El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
    Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
    Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
    Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
    Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption.
    Mittelman A; Bertram J; Henry DH; Snyder HW; Messerschmidt GL; Ciavarella D; Ainsworth S; Kiprov D; Arlin Z
    Semin Hematol; 1989 Apr; 26(2 Suppl 1):15-8. PubMed ID: 2658095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
    Shah R; Beem E; Sautina L; Zharikov SI; Segal MS
    Nephrol Dial Transplant; 2007 Feb; 22(2):617-20. PubMed ID: 17041000
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome.
    Camp-Sorrell D
    Oncol Nurs Forum; 2008 Jul; 35(4):593-6. PubMed ID: 18591164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced thrombotic microangiopathy.
    Zakarija A; Bennett C
    Semin Thromb Hemost; 2005 Dec; 31(6):681-90. PubMed ID: 16388419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption.
    Flam B; Sackey P; Berge A; Zachau AC; Brink B; Lundberg S
    J Nephrol; 2016 Oct; 29(5):711-4. PubMed ID: 26995001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.